Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial

BACKGROUND: von Hippel-Lindau disease (VHL) is a multisystem cancer syndrome caused by mutations in the VHL gene. Retinal hemangioblastoma is one of the most common tumours, and when it appears near the optic nerve, its treatment is challenging and risky. To date, no treatment has proven effective i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open Ophthalmol
Autors principals: González-Rodríguez, Beatriz, Villar Gómez de las Heras, Karina, Aguirre, Daniel T, Rodríguez-Padial, Luis, Albiñana, Virginia, Recio-Poveda, Lucía, Cuesta, Angel M, Botella, Luisa Mª, Jiménez-Escribano, Rosa María
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6557078/
https://ncbi.nlm.nih.gov/pubmed/31245608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2018-000203
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars